JENNIFER HOCUTT: Open Payments
NPI 1821654880 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 80 payments from 36 companies in 2025. Trend: 2023 $3,413 · 2024 $3,536 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $303 |
| AstraZeneca Pharmaceuticals LP | 4 | $196 |
| Travere Therapeutics, Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $121 |
| Merck Sharp & Dohme LLC | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| PFIZER INC. | 4 | $63 |
| Celgene Corporation | 4 | $61 |
| SpringWorks Therapeutics, Inc. | 2 | $51 |
Products named: Filspari, ZEPBOUND, TAGRISSO, PLUVICTO, KISQALI, ENHERTU, KEYTRUDA, Fabhalta.
Industry payments across AR — which companies pay providers there.
